Mouse Oncostatin M from StemCell Technologies, Inc.

Rabbit anti-QKI AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories

Direct ELISA Assay Diluent from BioFX Laboratories, Inc.

Assay Diluent from BioFX Laboratories, Inc.

Assay Diluent Trial Pack from BioFX Laboratories, Inc.

Rabbit anti-QKI AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories Direct ELISA Assay Diluent from BioFX Laboratories, Inc.Assay Diluent from BioFX Laboratories, Inc.Assay Diluent Trial Pack from BioFX Laboratories, Inc.

(Date:11/20/2009)...ited to contribute their abstracts to the World Co...e largest global meeting devoted to all aspects of...ent care. The Congress will be held in Florence, I...racts can be submitted online at http://www.iofwc...ruary 4, 2010. , IOF and ESCEO are pleased to an...

(Date:11/20/2009)...., November 19, 2009 The estimated 4.6 million Am...risk of developing respiratory symptoms due to poo...ionnaire study undertaken earlier this year by inv...f Veterinary Medicine. , The studywhich polled m...at 50 percent of individuals working in barns comp...

(Date:11/20/2009)...9th 2009 - Bacteria possess an ingenious mechanism...locks of the cell. This is the new finding of a te...B, a life sciences research institute in Flanders,...sel. The scientists made this discovery by modifyi...a coli . By means of this model organism, they hav...

Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2 Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3 Barn personnel experience higher-than-average rates of respiratory symptoms 2 Biologists discover bacterial defense mechanism against aggressive oxygen 2 Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1 Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2 Media Alert 3A July 10 Run Miles for Special Smiles 47691 1 Media Alert 3A July 10 Run Miles for Special Smiles 47691 2 Diplomat Specialty Pharmacy Promotes Rinku A Patel PharmD to Vice President Pharmacy Strategy 47686 1 Diplomat Specialty Pharmacy Promotes Rinku A Patel PharmD to Vice President Pharmacy Strategy 47686 2

[0] Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 [0] Barn personnel experience higher-than-average rates of respiratory symptoms [0] Biologists discover bacterial defense mechanism against aggressive oxygen

...he idea is to teach the immune system of children ... insulin-producing cells of the pancreas. , "We w...r, immunologist who directs the Medical College of...classified as an autoimmune disease because the im...ction, leaving young patients unable to use glucos...

... available in Spanish . , CAREFREE, A.Z. - Dat...l be released for the first time at the American A...cience of Cancer Health Disparities in Carefree, A...ority group in the United States, but little is kn...a Martinez, Ph.D., professor of epidemiology at Th...

...d. -- Scientists have recovered fossils from a 60-... and weight might make today,s anacondas and retic... Named Titanoboa cerrejonensis by its discovere...eighed 1,140 kilograms (2,500 pounds) and measured...t,s a conservative estimate. A report describing t...

Other Biology News:Molecule that suppresses immune response under study in type 1 diabetes 2 Molecule that suppresses immune response under study in type 1 diabetes 3 Hispanic women and breast cancer: An understudied group 2 Hispanic women and breast cancer: An understudied group 3 Hispanic women and breast cancer: An understudied group 4 At 2,500 pounds and 43 feet, prehistoric snake is the largest on record 2 At 2,500 pounds and 43 feet, prehistoric snake is the largest on record 3

Molecule that suppresses immune response under study in type 1 diabetes Hispanic women and breast cancer: An understudied group At 2,500 pounds and 43 feet, prehistoric snake is the largest on record

(Date:11/20/2009)...ETTLER TOLEDO recently announced that a free webin... Using At-Line Particle Characterization”, w...inar, the application of in situ particle characte...nd optimize a series of roller compaction runs whi...ompaction forces. , (PRWE...

(Date:11/19/2009)...to be able to charge their cell phones and other p...ecent discovery made by UC San Diego engineers cou...hat could do just this. , In recent research, p...andaru, a professor in the UCSD Department of Mech...ate student Mark Hoefer, have found that artificia...

(Date:11/19/2009)... Omeros Corporation (Nas...esults for the third quarter ended September 30, 2..., Omeros reported a net loss of $3.9 million, or $...million, or $2.54 per share, for the same period i...09, the Company reported a net loss of $15.5 milli...

(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...usly reported $6.3 million registered direct place...s of its common stock and warrants to purchase up ...

Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2 Nanotube defects equal better energy and storage systems 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8 Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2 Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3

[0] Roller Compaction Process Optimization Using At-Line Particle Characterization [0] Nanotube defects equal better energy and storage systems [0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights [0] Spherix Announces the Closing of $6.3 Million Registered Direct Offering

Products	Mouse Oncostatin M from StemCell Technologies, Inc.
Company	StemCell Technologies, Inc.
Item	Mouse Oncostatin M
Price
Description	Oncostatin M (OSM) is a pleiotropic cytokine produced by activated T cells, monocytes, and Kaposis sarcoma cells. OSM inhibits the growth of some tumour and normal cell lines, simulates fibroblast, smooth muscle and Kaposis sarcoma cell proliferation, cytokine release from endothelial cells and low density lipoprotein receptor expression on hepatoma cells. Mouse OSM was recently cloned and identified as an immediate early gene induced in various myeloid and lymphoid cell lines by a subset of cytokines including IL-2, IL-3, GM-CSF and EPO. For Research Purposes only. Not to be administered to humans.
Info	StemCell Technologies, Inc. 570 West Seventh Avenue, Suite 400 Vancouver, BC, V5Z 1B3 Canada Customer Service: (604) 877-0713 (800) 667-0322 Fax Number: (604) 877-0704 (800) 567-2899 Web Site: http://www.stemcell.com